Heart Test Laboratories (NASDAQ:HSCS – Get Free Report) announced its quarterly earnings data on Thursday. The company reported ($2.57) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($2.53) by ($0.04), Zacks reports.
Heart Test Laboratories Trading Down 4.6 %
NASDAQ HSCS opened at $2.91 on Friday. The company has a debt-to-equity ratio of 0.01, a current ratio of 1.72 and a quick ratio of 1.52. The stock has a market capitalization of $2.85 million, a P/E ratio of -0.37 and a beta of 2.76. The firm’s 50-day moving average is $3.45 and its two-hundred day moving average is $3.43. Heart Test Laboratories has a 12 month low of $2.36 and a 12 month high of $13.50.
Wall Street Analyst Weigh In
Separately, Maxim Group reissued a “buy” rating and issued a $12.00 price objective on shares of Heart Test Laboratories in a report on Wednesday, December 18th.
Heart Test Laboratories Company Profile
Heart Test Laboratories, Inc, a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals.
See Also
- Five stocks we like better than Heart Test Laboratories
- What Are Dividends? Buy the Best Dividend Stocks
- Casey’s Uptrend Remains Strong—New Highs on the Horizon
- How to Profit From Growth Investing
- Taiwan Semiconductor’s Huge U.S. Move—Stock Impact Ahead
- What Are the FAANG Stocks and Are They Good Investments?
- Why Costco Stock Is Poised to Hit $1,000 Again Soon
Receive News & Ratings for Heart Test Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Heart Test Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.
